HomeLatest NewsQuality NewsHHS Moves to Reduce Administrative Procedural Barriers to OUD Treatment

HHS Moves to Reduce Administrative Procedural Barriers to OUD Treatment

Physicians registered with the Drug Enforcement Administration will no longer need to meet the X-waiver requirement to prescribe treatments such as buprenorphine for opioid use disorder (OUD), U.S. Department of Health and Human Services (HHS) recently announced. HHS said it will publish updates to its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that expands access to medication-assisted treatment by exempting physicians from certain certification requirements.

The new policy potentially limits physicians to treating no more than 30 patients with buprenorphine for OUD at any single time. The HSS will make exceptions to this limit for hospital-based physicians, such as those working in emergency departments.

For more information on this policy, click here.

Stay Connected

Unified Voice Newsletter

Events This Month



08jun12:00 pm1:00 pmNursing Services Condition of ParticipationSDAHO Webinar

13jun12:00 pm1:00 pmAchieving Clinical Workforce Stability in the New NormalAHA Webinar

14jun10:00 am11:00 amThe Medicare "Must Knows" and Updates for Home HealthSDAHO Webinar

14jun12:00 pm1:00 pmBuprenorphine & its Efficacy for Patients with Serious Illness and End of Life Care SituationsSDAHO Webinar

By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact